Pancreatic endocrine neoplasms: a current update on genetics and imaging.
暂无分享,去创建一个
[1] C. Fletcher,et al. Diagnostic histopathology of tumors , 2013 .
[2] Nuria Peris Tomás,et al. [Pancreatic involvement in Von Hippel-Lindau disease]. , 2013, Gastroenterologia y hepatologia.
[3] 雅州 坂口,et al. [Von Hippel-Lindau disease]. , 2012 .
[4] R. Thakker,et al. Multiple endocrine neoplasia type 1. , 1999, Endocrine-related cancer.
[5] A. Andrén-sandberg. Pancreatic endocrine tumors , 2011, North American journal of medical sciences.
[6] M. Giovannini. Contrast-enhanced and 3-dimensional endoscopic ultrasonography. , 2010, Gastroenterology clinics of North America.
[7] B. Eriksson. New drugs in neuroendocrine tumors: rising of new therapeutic philosophies? , 2010, Current opinion in oncology.
[8] Z. Sparchez,et al. Contrast-enhanced ultrasound of the pancreas--a method beyond its potential or a new diagnostic standard? , 2009, Journal of gastrointestinal and liver diseases : JGLD.
[9] J. Norton,et al. Endocrine Neoplasms of the Pancreas , 2009 .
[10] G. Procopio,et al. Activity of sunitinib in patients with advanced neuroendocrine tumors. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] D. Metz,et al. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. , 2008, Gastroenterology.
[12] D. Bingham,et al. Inherited pancreatic endocrine tumor syndromes: Advances in molecular pathogenesis, diagnosis, management, and controversies , 2008, Cancer.
[13] S. Baldus,et al. High Expression of Heparanase is Significantly Associated with Dedifferentiation and Lymph Node Metastasis in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA and Via HIF1a to HB-EGF and bFGF , 2008, Journal of Gastrointestinal Surgery.
[14] D. Sahani,et al. Cystic pancreatic endocrine neoplasms: a distinct tumor type? , 2008, Journal of the American College of Surgeons.
[15] C. Rubio,et al. Somatostatinoma: Clinico‐pathological features of three cases and literature reviewed , 2008, Journal of gastroenterology and hepatology.
[16] R. Jensen,et al. Gastroenteropancreatic neuroendocrine tumours. , 2008, The Lancet. Oncology.
[17] A. Moser,et al. EUS-guided FNA diagnosis of pancreatic endocrine tumors: new trends identified. , 2008, Gastrointestinal endoscopy.
[18] Laura H. Tang,et al. Determining prognosis in patients with pancreatic endocrine neoplasms: can the WHO classification system be simplified? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] R. Salazar,et al. New drug development in digestive neuroendocrine tumors. , 2007, Annals of oncology : official journal of the European Society for Medical Oncology.
[20] M. Kulke,et al. Emerging therapies for the treatment of patients with advanced neuroendocrine tumors , 2007, Expert opinion on emerging drugs.
[21] James C Yao,et al. Neuroendocrine tumors. Molecular targeted therapy for carcinoid and islet-cell carcinoma. , 2007, Best practice & research. Clinical endocrinology & metabolism.
[22] L. Kvols,et al. A review of the current clinical trials for gastroenteropancreatic neuroendocrine tumours , 2007, Expert opinion on investigational drugs.
[23] F. Miller,et al. MRI of islet cell tumors of the pancreas. , 2006, AJR. American journal of roentgenology.
[24] Kentaro Takahashi,et al. [Von Hippel-Lindau disease]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[25] AB Trovó‐Marqui,et al. Neurofibromin: a general outlook , 2006, Clinical genetics.
[26] F. Meric-Bernstam,et al. Phase II study of RAD001 (everolimus) and depot octreotide (Sandostatin LAR) in patients with advanced low grade neuroendocrine carcinoma (LGNET). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] E. Maher,et al. Von Hippel-Lindau disease and endocrine tumour susceptibility. , 2006, Endocrine-related cancer.
[28] W. Knoefel,et al. Microadenomatosis of the Endocrine Pancreas in Patients With and Without the Multiple Endocrine Neoplasia Type 1 Syndrome , 2006, The American journal of surgical pathology.
[29] A. Bardia,et al. Hand-foot syndrome after dose-dense adjuvant chemotherapy for breast cancer: a case series. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] G. Åkerström,et al. Pancreatic tumours as part of the MEN-1 syndrome. , 2005, Best practice & research. Clinical gastroenterology.
[31] C. Bordi,et al. Aetiology, molecular pathogenesis and genetics , 2005 .
[32] W. Simonds,et al. Hereditary hormone excess: genes, molecular pathways, and syndromes. , 2005, Endocrine reviews.
[33] C. Johannessen,et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[34] R. Lloyd,et al. Preliminary results of a phase II trial of gefitinib in progressive metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study , 2005 .
[35] Y. Morioka,et al. Clinical pathology of endocrine tumors of the pancreas , 1991, Digestive Diseases and Sciences.
[36] C. Bordi,et al. Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics. , 2005, Best practice & research. Clinical gastroenterology.
[37] B. Sipos,et al. [Tumors of the endocrine pancreas]. , 2005, Der Pathologe.
[38] A. Knudson. Hereditary cancer: Two hits revisited , 2005, Journal of Cancer Research and Clinical Oncology.
[39] J. Neoptolemos,et al. Hereditary Pancreatic Endocrine Tumours , 2004, Pancreatology.
[40] A. McLean,et al. Endoscopic ultrasound in the detection of pancreatic islet cell tumours , 2004, Cancer imaging : the official publication of the International Cancer Imaging Society.
[41] G. Bommer,et al. Pancreatic glucagonoma with and without syndrome , 1980, Virchows Archiv A.
[42] M. Falconi,et al. Neuroendocrine pancreatic tumor: value of contrast enhanced ultrasonography. , 2004, Abdominal imaging.
[43] R. DeLellis. Pathology and genetics of tumours of endocrine organs , 2004 .
[44] G. Klöppel. [Tumors of the endocrine pancreas]. , 2005, Der Pathologe.
[45] R. Boldrini,et al. Malignant Pancreatic Endocrine Tumor in a Child With Tuberous Sclerosis , 2003, The American journal of surgical pathology.
[46] H. Gouya,et al. CT, endoscopic sonography, and a combined protocol for preoperative evaluation of pancreatic insulinomas. , 2003, AJR. American journal of roentgenology.
[47] J. Fletcher,et al. Preoperative detection of pancreatic insulinomas on multiphasic helical CT. , 2003, AJR. American journal of roentgenology.
[48] B. Teh. Multiple endocrine neoplasia , 2003, Journal of internal medicine.
[49] W. Frankel,et al. Neuroendocrine Carcinomas of the Pancreas With `Rhabdoid' Features , 2003, The American journal of surgical pathology.
[50] M. Fjällskog,et al. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[51] S. Rickes,et al. Differentiation of Neuroendocrine Tumors from Other Pancreatic Lesions by Echo-Enhanced Power Doppler Sonography and Somatostatin Receptor Scintigraphy , 2003, Pancreas.
[52] E. Fishman,et al. Helical CT of islet cell tumors of the pancreas: typical and atypical manifestations. , 2002, AJR. American journal of roentgenology.
[53] R. Reznek,et al. Imaging pancreatic islet cell tumours , 2002 .
[54] S. Curley,et al. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis. , 2002, Cancer research.
[55] M. Eledrisi,et al. Insulinoma in a patient with tuberous sclerosis: is there an association? , 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[56] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[57] A. Scarpa,et al. Role of disease‐causing genes in sporadic pancreatic endocrine tumors: MEN1 andVHL , 2001, Genes, chromosomes & cancer.
[58] G. Åkerström,et al. Multiple allelic deletions and intratumoral genetic heterogeneity in men1 pancreatic tumors. , 2001, The Journal of clinical endocrinology and metabolism.
[59] O. Iliopoulos. von Hippel-Lindau disease: genetic and clinical observations. , 2001, Frontiers of hormone research.
[60] S. Libutti,et al. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. , 2000, Surgery.
[61] S. Richard,et al. Pancreatic involvement in von Hippel–Lindau disease , 2000 .
[62] T. Ichikawa,et al. Islet cell tumor of the pancreas: biphasic CT versus MR imaging in tumor detection. , 2000, Radiology.
[63] B. Wiedenmann,et al. Endoscopic Ultrasonography of Neuroendocrine Tumours , 2000, Digestion.
[64] R. Semelka,et al. Neuroendocrine tumors of the pancreas: Spectrum of appearances on MRI , 2000, Journal of magnetic resonance imaging : JMRI.
[65] R. Jensen,et al. Genotype/phenotype correlation of multiple endocrine neoplasia type 1 gene mutations in sporadic gastrinomas. , 2000, The Journal of clinical endocrinology and metabolism.
[66] S. Richard,et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. , 2000, Gastroenterology.
[67] H. Höfler,et al. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[68] R. Jensen,et al. Pancreatic endocrine tumors: recent advances. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.
[69] S. Libutti,et al. Multiple neuroendocrine tumors of the pancreas in von Hippel-Lindau disease patients: histopathological and molecular genetic analysis. , 1998, The American journal of pathology.
[70] R. Snell,et al. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. , 1998, Human molecular genetics.
[71] F. Collins,et al. Somatic mutations of the MEN1 tumor suppressor gene in sporadic gastrinomas and insulinomas. , 1997, Cancer research.
[72] D. Chung,et al. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications. , 1997, The Journal of clinical investigation.
[73] B. Korf,et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.
[74] C. Larsson,et al. Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. , 1997, Human molecular genetics.
[75] J. Doppman,et al. Growth of newly diagnosed, untreated metastatic gastrinomas and predictors of growth patterns. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] F. Collins,et al. Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. , 1997, Cancer research.
[77] L. V. Van Hoe,et al. Helical CT for the preoperative localization of islet cell tumors of the pancreas: value of arterial and parenchymal phase images. , 1995, AJR. American journal of roentgenology.
[78] A. Dachman,et al. Islet cell tumors of the pancreas: pathologic-imaging correlation among size, necrosis and cysts, calcification, malignant behavior, and functional status. , 1995, AJR. American journal of roentgenology.
[79] A. Warshaw,et al. Cystic tumors of the pancreas. , 1995, The Surgical clinics of North America.
[80] A. Vinik,et al. Clinical review 72: diagnosis and management of functioning islet cell tumors. , 1995, The Journal of clinical endocrinology and metabolism.
[81] J. Howard,et al. Von recklinghausen's disease associated with duodenal somatostatinoma: Contrast of duodenal versus pancreatic somatostatinomas , 1995, Journal of surgical oncology.
[82] R. Jensen,et al. Endocrine tumors of the pancreas : recent advances in research and management , 1995 .
[83] G. Klöppel,et al. Histopathology and Immunopathology of Pancreatic Endocrine Tumors , 1994 .
[84] R. Semelka,et al. Islet cell tumors: comparison of dynamic contrast-enhanced CT and MR imaging with dynamic gadolinium enhancement and fat suppression. , 1993, Radiology.
[85] H. Brambs,et al. Pancreatic lesions in the von Hippel-Lindau syndrome. , 1991, Gastroenterology.
[86] D. Ballard,et al. Functioning insulinoma--incidence, recurrence, and long-term survival of patients: a 60-year study. , 1991, Mayo Clinic proceedings.
[87] M. Zinner,et al. Anatomic distribution of pancreatic endocrine tumors. , 1990, American journal of surgery.
[88] D. Henson,et al. Cystic tumors of the pancreas. , 1990, Pathology annual.
[89] D. Allison,et al. Endocrine tumors of the pancreas. , 1989, Radiologic clinics of North America.
[90] J. Norton,et al. Prospective Study of Gastrinoma Localization and Resection in Patients with Zollinger‐Ellison Syndrome , 1986, Annals of surgery.
[91] P. Sheedy,et al. CT features of nonfunctioning islet cell carcinoma. , 1984, AJR. American journal of roentgenology.
[92] T. Warner,et al. Immunohistochemical detection of chromogranin and neuron‐specific enolase in pancreatic endocrine neoplasms , 1984, The American journal of surgical pathology.
[93] R. Prinz,et al. Clinical aspects of glucagon-producing islet cell tumors. , 1981, The American journal of gastroenterology.
[94] H. Imhof,et al. Pancreatic calcifications in malignant islet cell tumors. , 1977, Radiology.